Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation

British Journal of Cancer

Volumn 90, Issue 12, 2004, Pages 2411-2417

  Boonstra, R ^a   Timmer Bosscha, H ^a   Van Echten Arends, J ^a   Van Der Kolk, D M ^a   Van Den Berg, A ^a   De Jong, B ^a   Tew, K D ^b   Poppema, S ^a   De Vries, E G E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

ABCA2; CGH; GLC4 MITO; Mitoxantrone; Multidrug resistance

Indexed keywords

ABC TRANSPORTER; ATP BINDING CASSETTE 2 PROTEIN; ESTRAMUSTINE; MESSENGER RNA; MITOXANTRONE; RNA; UNCLASSIFIED DRUG; ABCA2 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CELL CULTURE; CELL LINE; CHROMOSOME ANALYSIS; CHROMOSOME STRUCTURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; DRUG RESISTANCE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; NUCLEIC ACID HYBRIDIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, SMALL CELL; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MITOXANTRONE; NUCLEIC ACID HYBRIDIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 3042696864     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601863     Document Type: Article

References (35)

1. Allikmets R, Gerrard B, Hutchinson A, Dean M (1996) Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database. Hum Mol Genet 5: 1649-1655
2. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM (1999) Biochemical cellular and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39: 361-398
3. Bahram S, Arnold D, Bresnahan M, Strominger JL, Spies T (1991) Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. Proc Natl Acad Sci USA 88: 10094-10098
4. Borst P, Evers R, Kool M, Wijnholds J (1999) The multidrug resistance protein family. Biochim Biophys Acta 1461: 347-357
5. Diah SK, Smitherman PK, Aldridge J, Volk EL, Schneider E, Townsend AJ, Morrow CS (2001) Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins. Cancer Res 61: 5461-5467
6. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y Rishi AK, Ross DD (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95: 15665-15670
7. Hazlehurst LA, Foley NE, Gleason-Guzman MC, Hacker MP, Cress AE, Greenberger LW, De Jong MC, Dalton WS (1999) Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line. Cancer Res 59: 1021-1028
8. Hopper E, Belinsky MG, Zeng H, Tosolini A, Testa JR, Kruh GD (2001) Analysis of the structure and expression pattern of MRP7 (ABCC10) a new member of the MRP subfamily. Cancer Lett 162: 181-191
9. International Standing Committee on Human Cytogenetic Nomenclature (1995) In: Mittelman F (Ed). An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger AG
10. Jaiswal JK, Andrews NW, Simon SM (2002) Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells. J Cell Biol 159: 625-635
11. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821
12. Klein I, Sarkadi B, Varadi A (1999) An inventory of the human ABC proteins. Biochim Biophys Acta 1461: 237-262
13. Knutsen T, Rao VK, Ried T, Mickley L, Schneider E, Miyake K, Ghadimi BM, Padilla-Nash H, Pack S, Greenberger L, Cowan K, Dean M, Fojo T, Bates S (2000) Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines. Genes Chromosomes Cancer 27: 110-116
14. Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJ, Juijn JA, Baas F, Borst P (1997) Analysis of expression of cMOAT (MRP2) MRP3 MRP4 and MRP5 homologues of the multidrug resistance-associated protein gene (MRP1) in human cancer cell lines. Cancer Res 57: 3537-3547
15. Lage H, Perlitz C, Abele R, Tampé R, Dietel M, Schadendorf D, Sinha P (2001) Enhanced expression of human ABC transporter TAP is associated with cellular resistance to mitoxantrone. FEBS Lett 503: 179-184
16. Laing NM, Belinsky MG, Kruh GD, Bell DW, Boyd JT, Barone L, Testa JR, Tew KD (1998) Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells. Cancer Res 58: 1332-1337
17. Litman T, Brangi M, Hudson E, Fetsch P, Abati A, Ross DD, Miyake K, Resau JH, Bates SE (2000) The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter MXR (ABCG2). J Cell Sci 113(Part 11): 2011-2021
18. Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B, Brangi M, Greenberger L, Dean M, Fojo T, Bates SE (1999) Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res 59: 8-13
19. Nielsen D, Eriksen J, Maare C, Litman T, Kjaersgaard E, Plesner T, Friche E, Skovsgaard T (2000) Characterisation of non-P-glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantrone. Biochem Pharmacol 60: 363-370
20. Richard M, Drouin R, Beaulieu AD (1998) ABC50 a novel human ATP-binding cassette protein found in tumor necrosis factor-alpha-stimulated synoviocytes. Genomics 53: 137-145
21. Ross DD, Yang W, Abruzzo LV, Dalton WS, Schneider E, Lage H, Dietel M, Greenberger L, Cole SP, Doyle LA (1999) Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst 91: 429-433
22. Scheffer GL, Maliepaard M, Pijnenborg AC, van Gastelen MA, De Jong MC, Schroeijers AB, van der Kolk DM, Allen JD, Ross DD, van der Valk P, Dalton WS, Schellens JH, Scheper RJ. (2000) Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines. Cancer Res 60: 2589-2593
23. Smith CD, Zilfou JT, Zhang X, Hudes GR, Tew KD (1995) Modulation of P-glycoprotein activity by estramustine is limited by binding to plasma proteins. Cancer 75: 2597-2604
24. Speicher LA, Barone LR, Chapman AE, Hudes GR, Laing N, Smith CD, Tew KD (1994) P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine. J Natl Cancer Inst 86: 688-694
25. Timmer-Bosscha H, Hospers GA, Meijer C, Mulder NH, Muskiet FA, Martini IA, Uges DR, de Vries EG (1989) Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line. J Natl Cancer Inst 81: 1069-1075
26. Van der Kolk DM, Vellenga E, Scheffer GL, Muller M, Bates SE, Scheper RJ, de Vries EG (2002) Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia. Blood 99: 3763-3770
27. Van Luyn MJ, Muller M, Renes J, Meijer C, Scheper RJ, Nienhuis EF, Mulder NH, Jansen PL, de Vries EG (1998) Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug-resistance protein 1. Int J Cancer 76: 55-62
28. Versantvoort CH, Withoff S, Broxterman HJ, Kuiper CM, Scheper RJ, Mulder NH, de Vries EG (1995) Resistance-associated factors in human small-cell lung-carcinoma GLC4 sub-lines with increasing adriamycin resistance. Int J Cancer 61: 375-380
29. Volk EL, Rohde K, Rhee M, McGuire JJ, Doyle LA, Ross DD, Schneider E (2000) Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux. Cancer Res 60: 3514-3521
30. Vulevic B, Chen Z, Boyd JT, Davis Jr W, Walsh ES, Belinsky MG, Tew KD (2001) Cloning and characterization of human adenosine 5′-triphosphate- binding cassette sub-family A transporter 2 (ABCA2). Cancer Res 61: 3339-3347
31. Wielinga PR, van der Heijden I, Reid G, Beijnen JH, Wijnholds J, Borst P (2003) Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J Biol Chem 278: 17664-17671
32. Withoff S, de Vries EG, Keith WN, Nienhuis EF, van der Graaf WT, Uges DR, Mulder NH (1996) Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26 mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4. Br J Cancer 74: 1869-1876
33. Zhou C, Zhao L, Inagaki N, Guan J, Nakajo S, Hirabayashi T, Kikuyama S, Shioda S (2001) ATP-binding cassette transporter ABC2/ABCA2 in the rat brain: a novel mammalian lysosome-associated membrane protein and a specific marker for oligodendrocytes but not for myelin sheaths. J Neurosci 21: 849-857
34. Zijlstra JG, de Jong S, van de Grampel JC, de Vries EG, Mulder NH (1986) Different type of DNA damage caused by three aziridinyl substituted cyclophosphazenes in a human small cell lung carcinoma cell line. Cancer Res 46: 2726-2729
35. Zijlstra JG, de Vries EG, Mulder NH. 1987 Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 47: 1780-1784